Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China · Delayed Price · Currency is CNY 22.96
-0.49 (-2.09%)
Aug 31, 2026, 3:04 PM CST
Hybio Pharmaceutical Market Cap
Hybio Pharmaceutical has a market cap or net worth of 20.71 billion as of August 31, 2026. Its market cap has decreased by -10.19% in one year.
Market Cap
20.71B
Enterprise Value
22.49B
Revenue
1.11B
Ranking
n/a
PE Ratio
164.77
Stock Price
22.96
ChartMarket Cap Chart
Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 20.71B, an increase of 606.89%. That is a compound annual growth rate of 13.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 20.71B | 31.01% |
| Dec 31, 2025 | 15.81B | 38.87% |
| Dec 31, 2024 | 11.38B | -5.08% |
| Dec 29, 2023 | 11.99B | -22.75% |
| Dec 30, 2022 | 15.53B | 39.41% |
| Dec 31, 2021 | 11.14B | 88.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Walvax Biotechnology | 22.84B |
| Harbin Pharmaceutical Group | 22.67B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.39B |
| Tasly Pharmaceutical Group | 22.24B |
| Guangdong Zhongsheng Pharmaceutical | 21.97B |
| Jilin Aodong Pharmaceutical Group | 21.83B |
| Betta Pharmaceuticals | 21.27B |
| Livzon Pharmaceutical Group | 20.96B |